nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—Vomiting—Dactinomycin—testicular cancer	0.000717	0.000717	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—testicular cancer	0.000716	0.000716	CcSEcCtD
Gadobenate Dimeglumine—Rash—Dactinomycin—testicular cancer	0.000711	0.000711	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Ifosfamide—testicular cancer	0.000707	0.000707	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—testicular cancer	0.000705	0.000705	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Etoposide—testicular cancer	0.000704	0.000704	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Cisplatin—testicular cancer	0.000704	0.000704	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Etoposide—testicular cancer	0.000703	0.000703	CcSEcCtD
Gadobenate Dimeglumine—Pain—Etoposide—testicular cancer	0.000698	0.000698	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Etoposide—testicular cancer	0.000698	0.000698	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—testicular cancer	0.000684	0.000684	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Ifosfamide—testicular cancer	0.000683	0.000683	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Methotrexate—testicular cancer	0.000679	0.000679	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Methotrexate—testicular cancer	0.000674	0.000674	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Etoposide—testicular cancer	0.000672	0.000672	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Dactinomycin—testicular cancer	0.000669	0.000669	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Etoposide—testicular cancer	0.000667	0.000667	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Methotrexate—testicular cancer	0.000663	0.000663	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Ifosfamide—testicular cancer	0.000657	0.000657	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Cisplatin—testicular cancer	0.000656	0.000656	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—testicular cancer	0.000655	0.000655	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—testicular cancer	0.000652	0.000652	CcSEcCtD
Gadobenate Dimeglumine—Rash—Ifosfamide—testicular cancer	0.000651	0.000651	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Ifosfamide—testicular cancer	0.000651	0.000651	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Etoposide—testicular cancer	0.000648	0.000648	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Etoposide—testicular cancer	0.000645	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Etoposide—testicular cancer	0.000645	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—testicular cancer	0.000645	0.000645	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Methotrexate—testicular cancer	0.000643	0.000643	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Methotrexate—testicular cancer	0.000641	0.000641	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—testicular cancer	0.00064	0.00064	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Cisplatin—testicular cancer	0.000639	0.000639	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—testicular cancer	0.000633	0.000633	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—testicular cancer	0.000632	0.000632	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Methotrexate—testicular cancer	0.000624	0.000624	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Methotrexate—testicular cancer	0.000621	0.000621	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—testicular cancer	0.00062	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Methotrexate—testicular cancer	0.00062	0.00062	CcSEcCtD
Gadobenate Dimeglumine—Chills—Methotrexate—testicular cancer	0.000617	0.000617	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Ifosfamide—testicular cancer	0.000614	0.000614	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Cisplatin—testicular cancer	0.000609	0.000609	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—testicular cancer	0.000606	0.000606	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Methotrexate—testicular cancer	0.000603	0.000603	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—testicular cancer	0.000601	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Etoposide—testicular cancer	0.000601	0.000601	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—testicular cancer	0.0006	0.0006	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Methotrexate—testicular cancer	0.000599	0.000599	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Methotrexate—testicular cancer	0.000599	0.000599	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—testicular cancer	0.000593	0.000593	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—testicular cancer	0.000588	0.000588	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—testicular cancer	0.000587	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Methotrexate—testicular cancer	0.000586	0.000586	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Etoposide—testicular cancer	0.000585	0.000585	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—testicular cancer	0.000585	0.000585	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—testicular cancer	0.000584	0.000584	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—testicular cancer	0.000584	0.000584	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—testicular cancer	0.00058	0.00058	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Methotrexate—testicular cancer	0.000579	0.000579	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Etoposide—testicular cancer	0.000577	0.000577	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—testicular cancer	0.000575	0.000575	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Cisplatin—testicular cancer	0.000566	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Gadobenate Dimeglumine—Rash—Cisplatin—testicular cancer	0.000561	0.000561	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Cisplatin—testicular cancer	0.000561	0.000561	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—testicular cancer	0.00056	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—testicular cancer	0.00056	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Etoposide—testicular cancer	0.000558	0.000558	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—testicular cancer	0.000557	0.000557	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Methotrexate—testicular cancer	0.000556	0.000556	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—testicular cancer	0.000555	0.000555	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Methotrexate—testicular cancer	0.000553	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—testicular cancer	0.00054	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Methotrexate—testicular cancer	0.00054	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Etoposide—testicular cancer	0.000539	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—testicular cancer	0.000539	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—testicular cancer	0.000537	0.000537	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Methotrexate—testicular cancer	0.000536	0.000536	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—testicular cancer	0.000532	0.000532	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Cisplatin—testicular cancer	0.000529	0.000529	CcSEcCtD
Gadobenate Dimeglumine—Cough—Methotrexate—testicular cancer	0.000522	0.000522	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—testicular cancer	0.000522	0.000522	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—testicular cancer	0.00052	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Etoposide—testicular cancer	0.000519	0.000519	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Gadobenate Dimeglumine—Rash—Etoposide—testicular cancer	0.000514	0.000514	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Etoposide—testicular cancer	0.000514	0.000514	CcSEcCtD
Gadobenate Dimeglumine—Headache—Etoposide—testicular cancer	0.000511	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Methotrexate—testicular cancer	0.00051	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Methotrexate—testicular cancer	0.00051	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Methotrexate—testicular cancer	0.00051	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000506	0.000506	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Methotrexate—testicular cancer	0.000504	0.000504	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—testicular cancer	0.000501	0.000501	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—testicular cancer	0.000498	0.000498	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Methotrexate—testicular cancer	0.000493	0.000493	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Methotrexate—testicular cancer	0.000489	0.000489	CcSEcCtD
Gadobenate Dimeglumine—Infection—Methotrexate—testicular cancer	0.000485	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Etoposide—testicular cancer	0.000485	0.000485	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—testicular cancer	0.000484	0.000484	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—testicular cancer	0.000481	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Methotrexate—testicular cancer	0.000479	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—testicular cancer	0.000477	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—testicular cancer	0.000477	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—testicular cancer	0.000477	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—testicular cancer	0.000475	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Methotrexate—testicular cancer	0.000475	0.000475	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Methotrexate—testicular cancer	0.000472	0.000472	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—testicular cancer	0.000467	0.000467	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—testicular cancer	0.000465	0.000465	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—testicular cancer	0.000461	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—testicular cancer	0.000458	0.000458	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—testicular cancer	0.000457	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Methotrexate—testicular cancer	0.000457	0.000457	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—testicular cancer	0.000456	0.000456	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—testicular cancer	0.00045	0.00045	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—testicular cancer	0.000446	0.000446	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000445	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—testicular cancer	0.000444	0.000444	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—testicular cancer	0.000442	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—testicular cancer	0.00044	0.00044	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Methotrexate—testicular cancer	0.000439	0.000439	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Methotrexate—testicular cancer	0.000436	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Methotrexate—testicular cancer	0.000434	0.000434	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Methotrexate—testicular cancer	0.00043	0.00043	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—testicular cancer	0.000423	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000422	0.000422	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Methotrexate—testicular cancer	0.000421	0.000421	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Pain—Methotrexate—testicular cancer	0.000418	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000417	0.000417	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—testicular cancer	0.000416	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—testicular cancer	0.000415	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—testicular cancer	0.000413	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—testicular cancer	0.000411	0.000411	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—testicular cancer	0.000409	0.000409	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—testicular cancer	0.000407	0.000407	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Methotrexate—testicular cancer	0.000403	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—testicular cancer	0.000403	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Methotrexate—testicular cancer	0.0004	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—testicular cancer	0.000394	0.000394	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—testicular cancer	0.000391	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—testicular cancer	0.000391	0.000391	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Methotrexate—testicular cancer	0.000388	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Methotrexate—testicular cancer	0.000386	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Methotrexate—testicular cancer	0.000386	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—testicular cancer	0.00038	0.00038	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—testicular cancer	0.000376	0.000376	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—testicular cancer	0.000374	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—testicular cancer	0.000372	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000365	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—testicular cancer	0.000365	0.000365	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—testicular cancer	0.000363	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—testicular cancer	0.000362	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—testicular cancer	0.000362	0.000362	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—testicular cancer	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—testicular cancer	0.000361	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Methotrexate—testicular cancer	0.00036	0.00036	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Methotrexate—testicular cancer	0.000351	0.000351	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—testicular cancer	0.000349	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000346	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Methotrexate—testicular cancer	0.000346	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—testicular cancer	0.000337	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—testicular cancer	0.000336	0.000336	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—testicular cancer	0.000334	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Methotrexate—testicular cancer	0.000334	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—testicular cancer	0.000328	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—testicular cancer	0.000324	0.000324	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Methotrexate—testicular cancer	0.000323	0.000323	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—testicular cancer	0.000313	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—testicular cancer	0.000312	0.000312	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Methotrexate—testicular cancer	0.000311	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Rash—Methotrexate—testicular cancer	0.000308	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Methotrexate—testicular cancer	0.000308	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Headache—Methotrexate—testicular cancer	0.000306	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—testicular cancer	0.000302	0.000302	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—testicular cancer	0.000299	0.000299	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—testicular cancer	0.000291	0.000291	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Methotrexate—testicular cancer	0.00029	0.00029	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—testicular cancer	0.000289	0.000289	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—testicular cancer	0.000286	0.000286	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—testicular cancer	0.00028	0.00028	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—testicular cancer	0.000272	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—testicular cancer	0.000269	0.000269	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—testicular cancer	0.000267	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—testicular cancer	0.000267	0.000267	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—testicular cancer	0.000265	0.000265	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—testicular cancer	0.000251	0.000251	CcSEcCtD
